HomeInsightsStock Comparison

Ajanta Pharma Ltd vs Glenmark Pharmaceuticals Ltd Stock Comparison

Ajanta Pharma Ltd vs Glenmark Pharmaceuticals Ltd Stock Comparison

Last Updated on: Jun 07, 2025

Key Highlights

  • The Latest Trading Price of Ajanta Pharma Ltd is ₹ 2569 as of 06 Jun 15:30.
  • The P/E Ratio of Ajanta Pharma Ltd changed from 25.6 on March 2020 to 34.7 on March 2024 . This represents a CAGR of 6.27% over 5 yearsThe P/E Ratio of Glenmark Pharmaceuticals Ltd changed from 7.5 on March 2020 to 0 on March 2024 . This represents a CAGR of -100.00% over 5 years.
  • The Market Cap of Ajanta Pharma Ltd changed from ₹ 11921 crore on March 2020 to ₹ 28181 crore on March 2024 . This represents a CAGR of 18.78% over 5 yearsThe Market Cap of Glenmark Pharmaceuticals Ltd changed from ₹ 5814 crore on March 2020 to ₹ 27019 crore on March 2024 . This represents a CAGR of 35.97% over 5 years.
  • The revenue of Ajanta Pharma Ltd for the Mar '25 is ₹ 1188 crore as compare to the Dec '24 revenue of ₹ 1176 crore. This represent the growth of 1.02% The revenue of Glenmark Pharmaceuticals Ltd for the Mar '25 is ₹ 3267 crore as compare to the Dec '24 revenue of ₹ 3418 crore. This represent the decline of -4.41%.
  • The ebitda of Ajanta Pharma Ltd for the Mar '25 is ₹ 315.26 crore as compare to the Dec '24 ebitda of ₹ 351.27 crore. This represent the decline of -10.25% The ebitda of Glenmark Pharmaceuticals Ltd for the Mar '25 is ₹ 199.89 crore as compare to the Dec '24 ebitda of ₹ 631.36 crore. This represent the decline of -68.34%.
  • The net profit of Ajanta Pharma Ltd changed from ₹ 208.12 crore to ₹ 225.26 crore over 8 quarters. This represents a CAGR of 4.04% The net profit of Glenmark Pharmaceuticals Ltd changed from ₹ 173.13 crore to ₹ 4.38 crore over 8 quarters. This represents a CAGR of -84.09% .
  • The Dividend Payout of Ajanta Pharma Ltd changed from 25.99 % on March 2020 to 79.83 % on March 2024 . This represents a CAGR of 25.16% over 5 yearsThe Dividend Payout of Glenmark Pharmaceuticals Ltd changed from 5.21 % on March 2020 to 1.37 % on March 2024 . This represents a CAGR of -23.44% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Ajanta Pharma Ltd

  • Ajanta Pharma is a specialty pharmaceutical formulation company primarily with a well-diversified Branded Generics business spread across India, the Rest of Asia, and Africa.
  • The Company is involved in development, manufacturing and marketing of marketing of quality finished dosages in domestic and international markets.
  • It produces a comprehensive range of specialty products targeting different therapeutic segments.
  • It has strong chronic-focused product portfolio led by a first-to-market strategy and front-end presence which helps it outgrow the market. The company's business includes Branded Generics in emerging markets of Asia and Africa, Generics in the developed markets of USA and Institution sales.
  • The branded generics business is spread in India and more than 30 emerging countries across Africa, CIS, the Middle East and South East Asia.

About Glenmark Pharmaceuticals Ltd

  • Glenmark Pharmaceuticals Ltd was incorporated in November 18th, 1977.
  • The Company is actively involved in the discovery of new molecules both NCEs (new chemical entity) and NBEs (new biological entity).
  • It is engaged in the business of development, manufacture and marketing of pharmaceutical products both formulation and active pharmaceuticals ingredients to regulated and semi-regulated markets. The company has several molecules in various stages of pre-clinical and clinical development primarily focused in the areas of Oncology, Respiratory and Dermatology.
  • Its branded generics business has a significant presence in markets across emerging economies including India.
  • The company has 14 manufacturing facilities across US, India, Argentina, Czech Republic and Switzerland.

Ajanta Pharma Ltd News Hub

News

Ajanta Pharma to discuss results

Ajanta Pharma will hold a meeting of the Board of Directors of the Company on 30 April 202...

Read more

22 Apr 2025 17:19

News

Ajanta Pharma Ltd spurts 2.5%, up for five straight sessions

Ajanta Pharma Ltd rose for a fifth straight session today. The stock is quoting at Rs 2786...

Read more

03 Feb 2025 13:00

News

Ajanta Pharma to conduct board meeting

Ajanta Pharma will hold a meeting of the Board of Directors of the Company on 30 January 2...

Read more

17 Jan 2025 21:11

News

Ajanta Pharma Ltd slips for fifth straight session

Ajanta Pharma Ltd dropped for a fifth straight session today. The stock is quoting at Rs 2...

Read more

26 Dec 2024 13:35

News

Ajanta Pharma Ltd soars 1.25%, up for fifth straight session

Ajanta Pharma Ltd gained for a fifth straight session today. The stock is quoting at Rs 29...

Read more

22 Nov 2024 13:00

News

Ajanta Pharma Ltd gains for third straight session

Ajanta Pharma Ltd is up for a third straight session today. The stock is quoting at Rs 292...

Read more

19 Nov 2024 13:05

Glenmark Pharmaceuticals Ltd News Hub

News

Board of Glenmark Pharmaceuticals recommends final dividend

Glenmark Pharmaceuticals announced that the Board of Directors of the Company at its meeti...

Read more

24 May 2025 11:52

News

Glenmark Pharmaceuticals grants 1.19 lakh stock options under ESOS

The Board of Glenmark Pharmaceuticals at its meeting held on 22 May 2025 has granted 1,19,...

Read more

22 May 2025 16:03

News

Glenmark Pharmaceuticals announces board meeting date

Glenmark Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 2...

Read more

13 May 2025 15:58

News

Ichnos Glenmark Innovation receives USFDA fast track designation for ISB 2001

IGI (Ichnos Glenmark Innovation), a global, fully integrated clinical-stage biotechnology ...

Read more

05 May 2025 19:16

News

Glenmark Pharma's US arm set to launch generic Adderall tablets

The company will launch Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroampheta...

Read more

17 Apr 2025 08:04

News

Glenmark Pharmaceuticals allots 12,653 equity shares under ESOP

Glenmark Pharmaceuticals has allotted 12,653 equity shares under ESOP. Consequently, the p...

Read more

17 Apr 2025 20:08

SWOT Analysis Of Ajanta Pharma Ltd

Strength

3

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Glenmark Pharmaceuticals Ltd

Strength

4

S

Weakness

2

W

Opportunity

1

O

Threats

1

T

BlinkX Score for Ajanta Pharma Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Glenmark Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Ajanta Pharma Ltd and Glenmark Pharmaceuticals Ltd

Which company has a larger market capitalization, Ajanta Pharma Ltd or Glenmark Pharmaceuticals Ltd?

Market cap of Ajanta Pharma Ltd is 32,092 Cr while Market cap of Glenmark Pharmaceuticals Ltd is 44,869 Cr

What are the key factors driving the stock performance of Ajanta Pharma Ltd and Glenmark Pharmaceuticals Ltd?

The stock performance of Ajanta Pharma Ltd and Glenmark Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Ajanta Pharma Ltd and Glenmark Pharmaceuticals Ltd?

As of June 7, 2025, the Ajanta Pharma Ltd stock price is INR ₹2569.2. On the other hand, Glenmark Pharmaceuticals Ltd stock price is INR ₹1590.0.

How do dividend payouts of Ajanta Pharma Ltd and Glenmark Pharmaceuticals Ltd compare?

To compare the dividend payouts of Ajanta Pharma Ltd and Glenmark Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions